ENTPD1 and non-small cell lung carcinoma: Therefore, the CD39 upregulation on immune cells in TME suggests that the CD39 pathway may, in addition to PD-1 signaling, represent another relevant mechanism for tumor-induced immunosuppression in NSCLC (64).